Synge James 4
4 · Life360, Inc. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Synge James
Director
Transactions
- Sale
Common stock
2024-06-17$27.00/sh−17,955$484,785→ 3,966 total(indirect: By LLC) - Sale
Common stock
2024-06-17$27.00/sh−66,979$1,808,433→ 291,944 total
Holdings
- 70,573(indirect: By Trust)
Common stock
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to the full exercise by the underwriters of a greenshoe option of the previously reported underwritten secondary offering that closed on June 7, 2024.
- [F2]Includes 8,373 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F3]Includes common stock and the number of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX.
- [F4]The Reporting Person has shared investment control over Carthona Capital FS Pty Ltd. ("Carthona Capital"). Carthona Capital is a member of ICCA Labs, LLC, an entity that holds an aggregate of 8,219 shares of the Issuer's common stock. The number of shares sold and held as reported herein represents Carthona Capital's proportionate ownership interest in ICCA Labs, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F5]The Reporting Person has shared investment control of Stynge Pty Ltd ATF Sandy Bay Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.